Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results

Описание: Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell and the 'Squawk Box' team to break down the company's latest earnings report and its clinical trial results for weight-loss drug tirzepatide. Watch 2022 Berkshire Hathaway Annual Shareholders Meeting with Warren Buffett and Charlie Munger on Saturday, April 30 at 9:45 a.m. ET https://www.cnbc.com/brklive22/

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-n...
 
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook:
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-cred...

#CNBC
#CNBCTV